America authorizes the use of "Johnson & Johnson" vaccine for adults

The US Medicines Agency has authorized the emergency use of the "Johnson & Johnson" vaccine for adults, and the vaccine against the Covid-19 epidemic caused by the Corona virus.

The US government agreed to use the "Johnson & Johnson" single-dose vaccine to prevent the Corona virus, to allow millions of Americans to be immunized against the epidemic in the coming weeks, and to open the way for other countries to approve the vaccine.

The Food and Drug Administration announced its approval of the emergency use of the vaccine for adults in the age of eighteen and later, after its committee of external experts unanimously approved it, Friday.

Acting Commissioner of Administration Janet Woodcock said in a statement, "The licensing of this vaccine expands the availability of vaccines that are the best medical protection against (disease) Covid-19, which helps us fight this epidemic that has killed more than half a million people in the United States." .

In global trials of the vaccine, which included 44,000 individuals, it was found that it is 66 percent effective in preventing moderate and severe infection with the Coronavirus four weeks after vaccination, and by 100 percent in preventing hospitalization and death from the disease.

Trials have reported very limited number of serious side effects.

It also provided some preliminary evidence that it reduces symptom-free infections.

The Johnson & Johnson vaccine is expected to be widely used around the world due to its ability to be shipped and stored in regular refrigerators, making it easier to distribute compared to the Pfizer-Bionic and Dodina vaccines, which should be kept at freezing point.

Follow our latest local and sports news, and the latest political and economic developments via Google news